CARPINIELLO, BERNARDO
 Distribuzione geografica
Continente #
EU - Europa 368.086
NA - Nord America 33.403
AS - Asia 18.255
SA - Sud America 3.101
AF - Africa 461
OC - Oceania 106
Continente sconosciuto - Info sul continente non disponibili 20
Totale 423.432
Nazione #
IT - Italia 352.781
US - Stati Uniti d'America 32.658
SG - Singapore 6.884
CN - Cina 6.415
UA - Ucraina 4.016
NL - Olanda 3.197
BR - Brasile 2.471
SE - Svezia 2.257
VN - Vietnam 1.575
FI - Finlandia 1.420
FR - Francia 1.192
DE - Germania 1.181
GB - Regno Unito 1.141
HK - Hong Kong 879
CA - Canada 491
IN - India 472
KR - Corea 455
BD - Bangladesh 328
AR - Argentina 211
RU - Federazione Russa 186
IQ - Iraq 158
JP - Giappone 132
TR - Turchia 132
ID - Indonesia 123
MX - Messico 120
EC - Ecuador 115
ZA - Sudafrica 108
ES - Italia 98
AU - Australia 95
PK - Pakistan 94
PL - Polonia 89
PH - Filippine 85
CO - Colombia 84
MA - Marocco 70
VE - Venezuela 64
EG - Egitto 63
SA - Arabia Saudita 61
IE - Irlanda 59
UZ - Uzbekistan 58
IR - Iran 57
CH - Svizzera 56
BE - Belgio 54
KE - Kenya 50
AT - Austria 48
CL - Cile 48
RO - Romania 47
MY - Malesia 45
PY - Paraguay 41
JM - Giamaica 39
NO - Norvegia 31
DZ - Algeria 30
IL - Israele 30
JO - Giordania 30
AE - Emirati Arabi Uniti 26
PE - Perù 26
TH - Thailandia 26
TN - Tunisia 24
AZ - Azerbaigian 23
ET - Etiopia 23
BO - Bolivia 22
CZ - Repubblica Ceca 22
DK - Danimarca 22
NP - Nepal 22
LT - Lituania 19
PT - Portogallo 19
LB - Libano 18
UY - Uruguay 17
GR - Grecia 16
HU - Ungheria 16
KZ - Kazakistan 16
SN - Senegal 16
TW - Taiwan 16
BG - Bulgaria 15
CR - Costa Rica 15
MU - Mauritius 15
SK - Slovacchia (Repubblica Slovacca) 15
GT - Guatemala 14
HR - Croazia 14
NG - Nigeria 14
EU - Europa 13
PS - Palestinian Territory 13
DO - Repubblica Dominicana 12
HN - Honduras 12
OM - Oman 12
NI - Nicaragua 11
NZ - Nuova Zelanda 11
RS - Serbia 11
AL - Albania 10
PA - Panama 10
EE - Estonia 9
LV - Lettonia 9
QA - Qatar 9
AO - Angola 8
BH - Bahrain 8
GH - Ghana 7
KG - Kirghizistan 7
KW - Kuwait 7
MD - Moldavia 7
TT - Trinidad e Tobago 7
AM - Armenia 6
Totale 423.314
Città #
Cagliari 338.108
Uta 8.242
Singapore 3.309
Amsterdam 2.985
Chandler 2.617
Ashburn 2.348
Boardman 2.254
San Jose 2.223
Jacksonville 2.151
Dallas 2.078
Fairfield 1.866
Woodbridge 1.579
Ann Arbor 1.266
Wilmington 1.052
Houston 1.026
Nyköping 966
Beijing 949
Helsinki 797
Hong Kong 789
Hefei 767
Los Angeles 765
Boston 716
Seattle 701
Nanjing 640
Lauterbourg 602
Milan 584
Cambridge 579
Ho Chi Minh City 506
Council Bluffs 487
Rome 485
Seoul 430
Buffalo 421
New York 346
Hanoi 339
The Dalles 309
Santa Clara 292
Toronto 258
Dearborn 252
Shanghai 229
São Paulo 211
Shenyang 206
Tianjin 186
Nanchang 171
Verona 165
Changsha 163
San Diego 162
Hebei 147
Guangzhou 145
Chicago 139
Jiaxing 139
Orem 127
Redwood City 125
Frankfurt am Main 119
Dong Ket 114
Norwalk 113
Orange 103
Jinan 88
Tokyo 87
Naples 86
Washington 86
Zhengzhou 85
Brooklyn 84
London 84
Bologna 83
Munich 83
Redondo Beach 79
Phoenix 76
Rio de Janeiro 76
Florence 75
Haiphong 75
Chennai 71
Atlanta 69
Warsaw 68
Turin 67
Montreal 65
Ningbo 65
Nuremberg 60
Cardiff 58
Sassari 58
Johannesburg 56
Pune 55
Bari 54
Da Nang 54
Hangzhou 54
Nieuwegein 54
Saint Petersburg 54
Baghdad 52
Belo Horizonte 52
Tashkent 47
Denver 44
San Francisco 44
Brussels 43
Nairobi 43
Dublin 42
Mountain View 42
Padova 42
Redmond 41
Porto Alegre 40
Brasília 39
Catania 39
Totale 391.567
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.675
Violence and mental disorders. A retrospective study of people in charge of a community mental health center 4.481
Mortality in mental disorders: Are we approaching to close the gap respect to other medical specialties? The case of schizophrenia 4.253
Validation of the italian version of the compensatory eating and behaviors in response to alcohol consumption scale (CEBRACS) 4.239
Mental disorders in obese patients with and without metabolic syndrome 3.940
Psychopathology, psychosocial factors and obesity 3.843
The asthma-anxiety connection 3.725
Obesità, sindrome metabolica e comorbidità psichiatriche 3.709
Le psicoterapie 3.685
Obesità e qualità della vita 3.682
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 3.672
Role of palmitoylethanolamide (PEA) in depression: Translational evidence Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders 3.640
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 3.639
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.512
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 3.428
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.425
Duration of untreated illness as a key to early intervention in schizophrenia: A review 3.177
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.146
Obesity, alexithymia and psychopathology: A case-control study 3.103
Mental disorders in patients with metabolic syndrome. The key role of central obesity 3.030
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.018
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.889
Il modello alternativo del DSM-5 per i disturbi di personalità 2.711
Clinical global impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders 2.679
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.676
Obesità e psicopatologia 2.670
Obesità, sindrome metabolica e comorbidità psichiatriche 2.660
Obesità e psicopatologia 2.643
Obesità, sindrome metabolica e comorbidità psichiatriche 2.601
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.600
Biomarkers in aggression 2.547
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.513
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 2.489
Obesità e alessitimia 2.409
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 2.399
Obesità e comorbidità psichiatrica di Asse I: risultati di uno studio caso – controllo 2.383
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.355
Diagnostic reliability in schizoaffective disorder 2.300
Disturbi da uso di sostanze e malattie dentali: lo stato dell’arte 2.174
The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia 2.041
Obesità e alessitimia 2.038
Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study 2.001
Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report 2.001
Obesità, alessitimia e rappresentazione corporea: risultati di uno studio caso – controllo 1.997
Obesity and psychopathology. A study of psychiatric comorbidity among patients attending a specialist obesity unit 1.934
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? Results of a retrospective study 1.921
Unblending borderline personality and bipolar disorders 1.903
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.890
Mental health in transgender individuals: a systematic review 1.878
Clinicians’ attitudes to cardiac function monitoring guidelines during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness 1.878
Obesità e punteggi all’SCL-90-R 1.844
Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets 1.837
PALIPERIDONE PALMITATE IN ACUTE PATIENTS WITH SCHIZOPHRENIA - TREATMENT RESPONSE, SAFETY AND TOLERABILITY: A PROSPECTIVE FLEXIBLE DOSE STUDY IN PATIENTS PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ANTIPSYCHOTICS 1.834
Disturbi dell'Umore 1.806
Asthma and psychiatric disorders 1.798
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 1.684
Anatomical distribution and expression of CYP in humans: Neuropharmacological implications 1.679
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.662
Obesità e comorbidità psichiatrica di asse I: studio caso - controllo 1.661
Risk and resilience factors for specific and general psychopathology worsening in people with Eating Disorders during COVID-19 pandemic: a retrospective Italian multicentre study 1.641
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 1.625
First-episode psychosis and migration in Italy (PEP-Ita migration): A study in the Italian mental health services 1.624
Differenze di genere nella remissione e recovery di pazienti schizofrenici e schizoaffettivi: risultati di uno studio di coorte prospettico 1.619
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 1.613
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.602
The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review 1.588
The Italian version of the borderline personality disorder severity index IV: Psychometric properties, clinical usefulness, and possible diagnostic implications 1.583
Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder 1.569
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis 1.556
Estimating the impact of workplace bullying: humanistic and economic burden among workers with chronic medical conditions 1.551
Il disturbo bipolare e la comorbidità con i disturbi di personalità 1.515
Accuracy of self-assessment of real-life functioning in schizophrenia 1.502
Approccio al trattamento dell’obesità: 5 anni di esperienza in un team multidisciplinare metabolico - psicoeducazionale – motorio 1.487
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 1.474
Personalized psychiatry: Promises and pitfalls 1.473
How Is the History of Early Traumatic Exposure Associated With the Psychopathological Outcomes of COVID-19 Related Lockdown and Subsequent Re-opening in People With Eating Disorders? 1.465
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia 1.460
Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study 1.456
Disturbo da sintomi somatici e disturbi correlati 1.454
Obesità e disturbi d’ansia 1.441
Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy 1.437
Obesità e ansia 1.425
Schizofrenia e disturbo schizoaffettivo: differenze cliniche, di decorso, esito e trattamento 1.409
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 1.409
Big data in severe mental illness: the role of electronic monitoring tools and metabolomics 1.380
Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: A retrospective report on 434 patients with severe mental illness 1.371
Obesità e qualità della vita 1.361
Obesità e disturbi di personalità 1.359
Disturbi della nutrizione e dell'alimentazione 1.349
Haloperidol and loss of gray matter in schizophrenia: Reconciling meta-analytical results with molecular pharmacology 1.348
The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future 1.346
Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets 1.311
The reciprocal relationship between suicidality and stigma 1.310
Obesità e disturbi di personalità: risultati di uno studio caso - controllo 1.293
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia 1.284
Prevalence and clinical correlates of cognitive symptoms in depression: A naturalistic study 1.275
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.272
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.254
Obesità e disturbi di personalità 1.216
Le cure 1.213
Totale 220.927
Categoria #
all - tutte 641.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 641.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.655 0 0 0 0 0 0 0 0 0 0 0 2.655
2021/202220.439 2.074 1.744 1.090 1.523 1.842 1.450 973 905 1.419 1.601 2.815 3.003
2022/202333.545 2.927 2.859 2.970 2.628 2.664 3.452 1.397 6.784 2.294 1.687 2.351 1.532
2023/202444.625 2.576 1.506 2.647 4.157 3.964 7.633 6.465 3.063 2.217 3.347 3.666 3.384
2024/2025107.212 32.267 30.919 9.842 7.522 4.336 4.334 10.309 775 1.515 2.258 1.393 1.742
2025/202633.785 1.896 1.525 4.893 3.559 2.116 2.243 5.445 1.932 4.045 2.910 2.498 723
Totale 424.664